<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cost-Effectiveness in Hypertension &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cost-effectiveness-in-hypertension/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:52:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Cost-Effectiveness in Hypertension &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Study Shows Intensive Blood Pressure Targets Offer Cost-Effective Benefits</title>
		<link>https://bioengineer.org/study-shows-intensive-blood-pressure-targets-offer-cost-effective-benefits/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 19 Aug 2025 02:46:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cardiovascular risk reduction]]></category>
		<category><![CDATA[Clinical Simulation Studies]]></category>
		<category><![CDATA[Cost-Effectiveness in Hypertension]]></category>
		<category><![CDATA[Hypertension Treatment Guidelines]]></category>
		<category><![CDATA[Intensive Blood Pressure Control]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-shows-intensive-blood-pressure-targets-offer-cost-effective-benefits/</guid>

					<description><![CDATA[A groundbreaking simulation study conducted by researchers affiliated with Mass General Brigham presents compelling evidence favoring more aggressive blood pressure control in patients at high cardiovascular risk. The results, freshly published in the prestigious Annals of Internal Medicine, challenge conventional hesitations surrounding overtreatment in hypertension management. Utilizing rigorous data-driven methods, this research underscores the net [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">256270</post-id>	</item>
	</channel>
</rss>
